We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
451
DELISTED
Hologic
HOLX
| $1.11M | 0.02% |
51,560
-1,254,440
| -96% | -$27.1M |
|
|
PACD
452
DELISTED
Pacific Drilling S A
PACD
| $1.1M | 0.02% |
+10,090
| New | +$1.06M |
|
|
ROSE
453
DELISTED
ROSETTA RESOURCES INC
ROSE
| $1.09M | 0.02% |
23,462
-9,259
| -28% | -$420K |
|
454
Oneok
OKE
$57.2B
| $1.06M | 0.02% |
+17,970
| New | +$1.05M |
|
455
Myriad Genetics
MYGN
$270M
| $1.06M | 0.02% |
+31,060
| New | +$962K |
|
456
Southern Company
SO
$109B
| $1.05M | 0.02% |
23,842
+18,533
| +349% | +$777K |
|
457
Carnival Corporation Ltd
CCL
$38.1B
| $1.03M | 0.02% |
+27,245
| New | +$1.08M |
|
458
Carpenter Technology
CRS
$25.8B
| $1.01M | 0.02% |
15,300
+11,102
| +264% | +$670K |
|
|
MRSH
459
Marsh
MRSH
$90.5B
| $1.01M | 0.02% |
20,426
+4,326
| +27% | +$207K |
|
460
Accenture
ACN
$102B
| $1.01M | 0.02% |
+12,631
| New | +$1.04M |
|
|
CCXI
461
DELISTED
ChemoCentryx, Inc.
CCXI
| $1M | 0.02% |
+151,200
| New | +$1.05M |
|
462
NetApp
NTAP
$35B
| $993K | 0.02% |
26,897
+13,893
| +107% | +$562K |
|
463
Walt Disney
DIS
$167B
| $981K | 0.02% |
+12,243
| New | +$949K |
|
|
RAI
464
DELISTED
Reynolds American Inc
RAI
| $975K | 0.02% |
36,498
+28,298
| +345% | +$713K |
|
465
Intuit
INTU
$86.5B
| $964K | 0.02% |
12,401
+8,161
| +192% | +$623K |
|
466
Lam Research
LRCX
$367B
| $952K | 0.02% |
173,040
-67,190
| -28% | -$357K |
|
|
KATE
467
DELISTED
Kate Spade & Company
KATE
| $949K | 0.02% |
+25,575
| New | +$845K |
|
468
Allegion
ALLE
$13.4B
| $940K | 0.02% |
+18,001
| New | +$904K |
|
|
TWX
469
DELISTED
Time Warner Inc
TWX
| $933K | 0.02% |
+14,884
| New | +$934K |
|
|
DTV
470
DELISTED
DIRECTV COM STK (DE)
DTV
| $933K | 0.02% |
12,198
+7,522
| +161% | +$551K |
|
471
FirstEnergy
FE
$28B
| $927K | 0.02% |
27,230
-51,096
| -65% | -$1.62M |
|
472
Micron Technology
MU
$930B
| $920K | 0.01% |
38,875
+13,986
| +56% | +$332K |
|
473
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $916K | 0.01% |
+22,565
| New | +$934K |
|
474
Healthpeak Properties
DOC
$15.1B
| $908K | 0.01% |
25,693
-438,149
| -94% | -$15.1M |
|
|
GPOR
475
DELISTED
Gulfport Energy Corp.
GPOR
| $908K | 0.01% |
+12,750
| New | +$783K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.